Trial Profile
Effect of Florbenazine-F18 for diagnosis in patients with vascular parkinsonism
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 14 Jul 2017
Price :
$35
*
At a glance
- Drugs Florbenazine F18 (Primary)
- Indications Parkinsonian disorders
- Focus Diagnostic use
- 14 Jul 2017 New trial record
- 08 Jun 2017 Preliminary results (n=10) presented at the 21st International Congress of Parkinson's Disease and Movement Disorders